Drug Companies Oppose Moves to Reimburse Off-Label Medicine

Pharmaceutical companies are pushing back against decisions by cash-strapped European governments to reimburse patients for drugs that haven't been approved to treat their conditions.



from WSJ.com: US Business http://ift.tt/1oyaFz3

via IFTTT